Friday, April 29, 2016

BRIEF-European regulators recommends approval of Gilead's new HIV treatment

* EU Medicines Agency recommends approval of Biogen Inc

and AbbVie Inc's daclizumab to treat multiple

sclerosis

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)